Reduction of a disulfide bond by β-adrenergic agonists: Evidence in support of a general "reductive activation" hypothesis for the mechanism of action of adrenergic agents

Douglas A. Peterson, Jon M. Gerrard

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

β-adrenergic agonists, but not antagonists, were found to reduce the disulfide bond of 5,5′-dithiobis-2-nitrobenzoic acid (DTNB). The extent of DTNB reduction was proportional to the intrinsic activity for these agonists. The results suggest a novel mechanism for transmission of the signal when a β-adrenergic agonist occupies its receptor. We propose that β-adrenergic agonists exert their effects to activate the adenylate cyclase by reducing a disulfide bond in the receptor (R) or guanyl nucleotide binding protein (G) component of the adenylate cyclase complex leading to tight binding of GTP to G and activation of G.

Original languageEnglish (US)
Pages (from-to)45-49
Number of pages5
JournalMedical Hypotheses
Volume22
Issue number1
DOIs
StatePublished - Jan 1987

Bibliographical note

Funding Information:
Grant support from MRC grant MA7396 is acknowledged. DAP is the recipient of a Veterans Administration Research Career Development Award and JMG is the recipient of an MRC Scientist Award. We are grateful to the technical assistance of R. Peterson, A. Crockett, A. Bress and B. McCoy and to Lori Devlin for typing this manuscript.

Fingerprint

Dive into the research topics of 'Reduction of a disulfide bond by β-adrenergic agonists: Evidence in support of a general "reductive activation" hypothesis for the mechanism of action of adrenergic agents'. Together they form a unique fingerprint.

Cite this